APP and neurodegenerative disease: Moreover, a literature review on the top ranked hub-bottlenecks and the seed protein explains that App (Amyloid beta A4 protein), the novel biomarker of neurodegenerative disease development, is down-regulated in the proteome profile of severe cases of COVID-19.